Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.39 USD
0.1%
Market Closed
Updated:
May 12, 2024
Prestige Consumer Healthcare Inc
Long-Term Debt
|
Prestige Consumer Healthcare Inc
Long-Term Debt Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Long-Term Debt
$1.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
2%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Long-Term Debt
$25.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Long-Term Debt
$49.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
54%
|
CAGR 10-Years
21%
|
|
|
Pfizer Inc
NYSE:PFE
|
Long-Term Debt
$61.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Long-Term Debt
$31.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Long-Term Debt
$24.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
17%
|
See Also
What is Prestige Consumer Healthcare Inc's Long-Term Debt?
Long-Term Debt
1.2B
USD
1.2B
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Long-Term Debt amounts to 1.2B USD.
What is Prestige Consumer Healthcare Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
2%
2%
Over the last year, the Long-Term Debt growth was -16%. The average annual Long-Term Debt growth rates for Prestige Consumer Healthcare Inc have been -8% over the past three years , -8% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
